Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2022
November 2022, Vol 12, No 11
November 2022, Vol 12, No 11
Overcoming Challenges in the Treatment of Primary Brain Tumors
By
William King
ESMO 2022 Highlights
In a special symposium held during the European Society for Medical Oncology Congress 2022, experts discussed lessons learned in the diagnosis and treatment of patients with primary brain tumors and what is on the horizon.
Read More ›
The Cures Act Information Blocking Rule: Impact on Data Access, Interoperability, and Security
By
Kem Tolliver, CMOM, CPC, CMPE
Practice Management
To be compliant and offer the best support to their patients, healthcare providers need to understand the provisions of the Final Rule as it pertains to creating, maintaining, and sharing patient health data, and the impact of this legislation on their practices.
Read More ›
Implementing a Transportation Hub: A Holistic Approach to a Systemic Problem
Advocacy
When patients do not have reliable transportation, they cannot receive care for their cancer. Rachel Marquez, BS, MPH, Regional Operations Leader, Galileo Health, New York City, was determined to change this and set up a thriving pilot transportation program at her cancer center, Cone Health.
Read More ›
Early Detection Blood Test May Change Cancer Screening Paradigms
By
Patricia Stewart
ESMO 2022 Highlights
New results from the PATHFINDER clinical trial suggest that a multicancer early detection blood test can accurately identify the presence of cancer in apparently healthy people.
Read More ›
Results from Phase 3 Trial Show Similar Efficacy and Safety Outcomes with CT-P16 versus Bevacizumab in Patients with NSCLC
By
William King
ESMO 2022 Highlights
One-year follow-up data from a phase 3 study found similar duration of response, time to progression (TTP), and survival rates with the biosimilar candidate CT-P16 compared with its reference drug, bevacizumab (Avastin), in the first-line treatment of patients with metastatic or recurrent nonsquamous non–small-cell lung cancer (NSCLC).
Read More ›
Increased Biosimilar Use Translates to Substantial Savings for Oncology Practices
By
William King
Biosimilars
The increased use of biosimilars within the US Oncology Network generated more than $6 million of savings in the Centers for Medicare & Medicaid Services’ Oncology Care Model (OCM) during the first half of 2020.
Read More ›
Biosimilar Substitution May Reduce Financial Risk to Providers in Value-Based Payment Models
By
William King
Biosimilars
Providers participating in the Centers for Medicare & Medicaid Services’ (CMS’) value-based payment (VBP) models may realize a reduction in financial risk via biosimilar substitution.
Read More ›
Generic and Biosimilar Drugs Generate a Record $373 Billion for America’s Patients and Healthcare System in 2021
Biosimilars
On September 21, 2022, the Association for Accessible Medicines (AAM), the leading trade association for generic and biosimilar manufacturers, released its 2022 U.S. Generic & Biosimilar Medicines Savings Report highlighting the value of generic and biosimilar medicines.
Read More ›
The Enduring Effects of the ACA on Disparities in Cancer Care
Healthcare Disparities
Navigating the health insurance landscape in the United States is confusing—and particularly so in light of the ever-changing expansions under the Affordable Care Act (ACA)—but understanding the many existing disparities in cancer-related care and coverage can help providers to offer the best care possible to their patients and to find solutions for those who might be getting left behind.
Read More ›
International Cholangiocarcinoma Patient Registry Accelerates and Supports CCA Research
Cholangiocarcinoma
The Cholangiocarcinoma Foundation hosts a patient registry, the International Cholangiocarcinoma Patient Registry (ICPR), that is a global database comprising patient medical histories and treatments for cholangiocarcinoma (CCA).
Read More ›
Page 1 of 2
1
2
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Out Models Cost Patients and Employers More Than They Disclose
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By
Marianne Davies, DNP, ACNP, AOCNP, FAAN
;
Shawn Perkins, RN, BSN, OCN
3.
Dexamethasone-Sparing Regimen Safe and Effective in Frail Patients with Multiple Myeloma
By
William King
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes